益盛药业
(002566)
| 流通市值：16.62亿 | | | 总市值：23.73亿 |
| 流通股本：2.32亿 | | | 总股本：3.31亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 159,128,536.54 | 668,468,926 | 505,560,683.83 | 347,843,789.44 |
| 营业收入 | 159,128,536.54 | 668,468,926 | 505,560,683.83 | 347,843,789.44 |
| 二、营业总成本 | 148,077,625.71 | 640,516,780.87 | 487,965,647.77 | 326,286,522.05 |
| 营业成本 | 39,980,766.05 | 170,640,668.91 | 127,426,515.18 | 81,050,490.29 |
| 税金及附加 | 4,044,553.16 | 16,014,107.3 | 12,201,006.81 | 8,153,834.53 |
| 销售费用 | 76,154,213.27 | 331,962,541.02 | 250,447,895.37 | 173,801,224.88 |
| 管理费用 | 21,008,731.19 | 98,100,850.88 | 79,161,265.71 | 52,684,305.86 |
| 研发费用 | 3,886,170.86 | 16,224,404.19 | 14,377,485.51 | 9,552,824.22 |
| 财务费用 | 3,003,191.18 | 7,574,208.57 | 4,351,479.19 | 1,043,842.27 |
| 其中:利息费用 | 3,225,556.51 | 13,844,030.81 | 10,457,864.16 | 6,863,205.83 |
| 其中:利息收入 | 255,713.41 | 6,405,885.13 | 6,225,138.24 | 5,924,883.36 |
| 加:公允价值变动收益 | 1,032,961.81 | 6,689,479.59 | 263,240.46 | -411,134.86 |
| 加:投资收益 | -158,773.13 | 5,285,761.43 | 4,793,304.18 | 4,699,387.52 |
| 资产处置收益 | - | 291,436.9 | 381,486.73 | 381,486.73 |
| 资产减值损失(新) | - | -1,590,887.57 | - | - |
| 信用减值损失(新) | -1,209,815.39 | -22,220.28 | -147,512.37 | -349,419.19 |
| 其他收益 | 3,564,183.25 | 22,755,117.72 | 17,357,127.76 | 14,693,350.96 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 14,279,467.37 | 61,360,832.92 | 40,242,682.82 | 40,570,938.55 |
| 加:营业外收入 | 155,207.59 | 71,182.51 | 67,092.4 | 46,760.21 |
| 减:营业外支出 | 129,890.95 | 1,884,142.71 | 1,930,428.19 | 1,737,016.71 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 14,304,784.01 | 59,547,872.72 | 38,379,347.03 | 38,880,682.05 |
| 减:所得税费用 | 2,268,147.59 | 8,891,478.9 | 4,976,911.5 | 5,518,968.3 |
| 六、净利润 | 12,036,636.42 | 50,656,393.82 | 33,402,435.53 | 33,361,713.75 |
| 持续经营净利润 | 12,036,636.42 | 50,656,393.82 | 33,402,435.53 | 33,361,713.75 |
| 归属于母公司股东的净利润 | 11,861,570.02 | 52,086,058.77 | 35,864,778.97 | 33,335,808.28 |
| 少数股东损益 | 175,066.4 | -1,429,664.95 | -2,462,343.44 | 25,905.47 |
| (一)基本每股收益 | 0.04 | 0.16 | 0.11 | 0.1 |
| (二)稀释每股收益 | 0.04 | 0.16 | 0.11 | 0.1 |
| 九、综合收益总额 | 12,036,636.42 | 50,656,393.82 | 33,402,435.53 | 33,361,713.75 |
| 归属于母公司股东的综合收益总额 | 11,861,570.02 | 52,086,058.77 | 35,864,778.97 | 33,335,808.28 |
| 归属于少数股东的综合收益总额 | 175,066.4 | -1,429,664.95 | -2,462,343.44 | 25,905.47 |
| 公告日期 | 2025-04-24 | 2025-04-18 | 2024-10-26 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |